Jacqueline E. Noll
North Terrace
Adelaide, SA 5005, Australia
Adelaide, SA 5005, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Therapeutic inhibition of myeloperoxidase with AZD5904 attenuates disease progression in mouse models of early-stage and relapsed multiple myeloma.
Journal: Haematologica
Published: December 15, 2025
Mer receptor expression promotes multiple myeloma disease development via a cell-extrinsic mechanism.
Journal: Experimental hematology
Published: January 09, 2025
Molecular and cellular mechanisms of chemoresistance in paediatric pre-B cell acute lymphoblastic leukaemia.
Journal: Cancer metastasis reviews
Published: May 31, 2024
Myeloperoxidase creates a permissive microenvironmental niche for the progression of multiple myeloma.
Journal: British journal of haematology
Published: May 25, 2023
Fragmentation of tissue-resident macrophages during isolation confounds analysis of single-cell preparations from mouse hematopoietic tissues.
Journal: Cell reports
Published: April 21, 2021
Macrophages in multiple myeloma: key roles and therapeutic strategies.
Journal: Cancer metastasis reviews
Published: August 13, 2020
CKLF and IL1B transcript levels at diagnosis are predictive of relapse in children with pre-B-cell acute lymphoblastic leukaemia.
Journal: British journal of haematology
Published: July 10, 2020
Characterization of the role of Samsn1 loss in multiple myeloma development.
Journal: FASEB bioAdvances
Published: April 26, 2020
GLIPR1 expression is reduced in multiple myeloma but is not a tumour suppressor in mice.
Journal: PloS one
Published: October 17, 2019
LCRF-0006, a small molecule mimetic of the N-cadherin antagonist peptide ADH-1, synergistically increases multiple myeloma response to bortezomib.
Journal: FASEB bioAdvances
Published: August 28, 2019
Last Updated: 09/26/2026